Bevacizumab Intravenous and Insulin degludec Subcutaneous
Determining the interaction of Bevacizumab Intravenous and Insulin degludec Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: bevacizumab
Brand name: Avastin, Mvasi
Synonyms: Bevacizumab
Generic Name: insulin degludec
Brand name: Tresiba, Tresiba FlexTouch
Synonyms: Insulin degludec, Insulin Degludec
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Bevacizumab Intravenous-Insulin detemir
- Bevacizumab Intravenous-Insulin Detemir (Cartridges and Prefilled Syringes)
- Bevacizumab Intravenous-Insulin Detemir (Vials)
- Bevacizumab Intravenous-Insulin detemir Subcutaneous
- Bevacizumab Intravenous-Insulin glargine
- Bevacizumab Intravenous-Insulin Glargine (U-100) Cartridge Systems and Pens
- Insulin degludec Subcutaneous-Bevacizumab-awwb
- Insulin degludec Subcutaneous-Bevacizumab-awwb Intravenous
- Insulin degludec Subcutaneous-Bevespi Aerosphere
- Insulin degludec Subcutaneous-Bevyxxa
- Insulin degludec Subcutaneous-Bexarotene
- Insulin degludec Subcutaneous-Bexarotene (Systemic)